Dr. Aseem Malhotra

And in that book, there are recipes and a diet plan and everything else. And it explains the whole cholesterol issue and heart disease reversing as well.

And in that book, there are recipes and a diet plan and everything else. And it explains the whole cholesterol issue and heart disease reversing as well.

BMJ.

BMJ.

BMJ.

Yeah, absolutely, Megan. So medical knowledge is under commercial control, but most doctors don't know that. And just to give you how bad the situation is, 20 to 50% of all healthcare activity in the United States, and you spend almost more than $4 trillion in healthcare, actually brings no benefit to the patient is wasteful or harmful.

Yeah, absolutely, Megan. So medical knowledge is under commercial control, but most doctors don't know that. And just to give you how bad the situation is, 20 to 50% of all healthcare activity in the United States, and you spend almost more than $4 trillion in healthcare, actually brings no benefit to the patient is wasteful or harmful.

Yeah, absolutely, Megan. So medical knowledge is under commercial control, but most doctors don't know that. And just to give you how bad the situation is, 20 to 50% of all healthcare activity in the United States, and you spend almost more than $4 trillion in healthcare, actually brings no benefit to the patient is wasteful or harmful.

And the reason for this is that most doctors and policymakers are unaware of the poor quality research that drives overuse in terms of overmedicated people, underuse of simpler, safer lifestyle options, avoidable adverse events, waste, and missed opportunities to give the right patient the right treatment at the right time. So that's really the major issue here.

And the reason for this is that most doctors and policymakers are unaware of the poor quality research that drives overuse in terms of overmedicated people, underuse of simpler, safer lifestyle options, avoidable adverse events, waste, and missed opportunities to give the right patient the right treatment at the right time. So that's really the major issue here.

And the reason for this is that most doctors and policymakers are unaware of the poor quality research that drives overuse in terms of overmedicated people, underuse of simpler, safer lifestyle options, avoidable adverse events, waste, and missed opportunities to give the right patient the right treatment at the right time. So that's really the major issue here.

And the way to overcome this or to solve this problem is to make sure that drug trials are independently evaluated or take things further. I mean, if you look at the history of the drug industry over the last few decades, most drugs they produce are copies of old ones.

And the way to overcome this or to solve this problem is to make sure that drug trials are independently evaluated or take things further. I mean, if you look at the history of the drug industry over the last few decades, most drugs they produce are copies of old ones.

And the way to overcome this or to solve this problem is to make sure that drug trials are independently evaluated or take things further. I mean, if you look at the history of the drug industry over the last few decades, most drugs they produce are copies of old ones.

They take an old generic drug, they change the molecules here and there, they patent it, make lots of money, which is, of course, a huge waste. The American taxpayer, American public are paying lots of money for something that could be a lot cheaper with an old generic drug.

They take an old generic drug, they change the molecules here and there, they patent it, make lots of money, which is, of course, a huge waste. The American taxpayer, American public are paying lots of money for something that could be a lot cheaper with an old generic drug.

They take an old generic drug, they change the molecules here and there, they patent it, make lots of money, which is, of course, a huge waste. The American taxpayer, American public are paying lots of money for something that could be a lot cheaper with an old generic drug.

And then, of course, there's the harm issue, because what they do is the results of their trials that they design, they control, they analyze, they publish in medical journals, who, by the way, take a lot of money from industry as well, which comes out in the film, will grossly exaggerate the safety and benefits of those drugs. So no informed consent is truly happening.

And then, of course, there's the harm issue, because what they do is the results of their trials that they design, they control, they analyze, they publish in medical journals, who, by the way, take a lot of money from industry as well, which comes out in the film, will grossly exaggerate the safety and benefits of those drugs. So no informed consent is truly happening.

And then, of course, there's the harm issue, because what they do is the results of their trials that they design, they control, they analyze, they publish in medical journals, who, by the way, take a lot of money from industry as well, which comes out in the film, will grossly exaggerate the safety and benefits of those drugs. So no informed consent is truly happening.